Scientific Opinion on the substantiation of a health claim related to isoleucyl-prolyl-proline (IPP) and valyl-prolyl-proline (VPP) and maintenance of normal blood pressure pursuant to Article 13(5) of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 9, Issue 9, 2011, Pages

[No Author Info available]

Author keywords

blood pressure; health claims; IPP; Isoleucyl prolyl proline; valyl prolyl proline; VPP

Indexed keywords

EID: 84954538510     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2011.2380     Document Type: Article

References (36)

1. Cicero AFG, Gerocami B, Laghi L and Borghi C, 2011. Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials. Journal of Human Hypertension, 25, 425–436.
2. De Leeuw PW, Van der Zander K, Kroon AA, Rennenberg RM and Koning MM, 2009. Dose-dependent lowering of blood pressure by dairy peptides in mildly hypertensive subjects. Blood Pressure, 18, 44–50.
3. Ehlers PI, Kivimaki AS, Turpeinen AM, Korpela R and Vapaatalo H, 2011. High blood pressure-lowering and vasoprotective effects of milk products in experimental hypertension. British Journal of Nutrition, 10, 1–11.
4. Engberink MF, Schouten EG, Kok FJ, van Mierlo LA, Brouwer IA and Geleijnse JM, 2008. Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial. Hypertension, 51, 399–405.
5. Foltz M, Meynen EE, Bianco V, van Platerink C, Koning TM and Kloek J, 2007. Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. Journal of Nutrition, 137, 953–958.
6. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y and Takano T, 1996. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. American Journal of Clinical Nutrition, 64, 767–771.
7. Hirata H, Nakamura Y, Yada H, Moriguchi S, Kajimoto O and Takahashi T, 2002. Clinical effects of new sour milk drink in mild or moderate hypertensive subjects. Journal of New Remedies & Clinics, 51, 61–69.
8. Jakala P, Pere E, Lehtinen R, Turpeinen A, Korpela R and Vapaatalo H, 2009a. Cardiovascular activity of milk casein-derived tripeptides and plant sterols in spontaneously hypertensive rats. Journal of Physiology and Pharmacology, 60, 11–20.
9. Jakala P, Hakala A, Turpeinen AM, Korpela R and Vapaatalo H, 2009b. Casein-derived bioactive tripeptides IPP and VPP attenuate the development of hypertension and improve endothelial function in salt-loaded Goto-Kakizaki; rats. Journal of Functional Foods, 1, 366–374.
10. Jakala P, Turpeinen A, Rajakari K, Korpela R and Vapaatalo H, 2010. Biological effects of casein-derived tripeptide powders are not affected by fermentation process. International Dairy Journal, 20, 366–370.
11. Jauhiainen T, Collin M, Narva M, ZhongJian C, Poussa T, Vapaatalo H and Korpela R, 2005b. Effect of long-term intake of milk peptides and minerals on blood pressure and arterial function in spontaneously hypertensive rats. Milchwissenschaft, 60, 358–363.
12. Jauhiainen T, Ronnback M, Vapaatalo H, Wuolle K, Kautiainen H, Groop PH and Korpela R, 2010a. Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects. European Journal of Clinical Nutrition, 64, 424–431.
13. Jauhiainen T, Pilvi T, Cheng ZJ, Kautiainen H, Muller DN, Vapaatalo H, Korpela R and Mervaala E, 2010b. Milk Products Containing Bioactive Tripeptides Have an Antihypertensive Effect in Double Transgenic Rats (dTGR) Harbouring Human Renin and Human Angiotensinogen Genes. Journal of Nutrition and Metabolism, pii: 287030. Epub 2009 Nov 30.
14. Kajimoto O, Nakamura Y, Yada H, Moriguchi S, Hirata H and Takahashi T, 2001a. Hypotensive effects of sour milk in subjects with mild or moderate hypertension. Japan Society of Nutrition and Food Science, 54, 347–354.
15. Kajimoto O, Aihara K, Hirata H, Takahashi R and Nakamura Y, 2001b. Hypotensive effects of the tablets containing “lactotripeptides (VPP, IPP)”. Journal of Nutritional Food, 4, 51–61.
16. Kajimoto O, Kurosaki T, Mizutani J, Ikeda N, Kaneko K, Yabune M and Nakamura Y, 2002. Antihypertensive effects of the liquid yogurt containing “lactotripeptides (VPP, IPP)” in mild hypertensive subjects. Journal of Nutritional Food, 5, 55–66.
17. Lehtinen R, Jauhiainen T, Kankuri E, Lindstedt K, Kovanen PT, Kerojoki O, Korpela R and Vapaatalo H, 2010. Effects of milk casein-derived tripeptides Ile-Pro;-Pro, Val-Pro;-Pro, and Leu-Pro;-Pro on enzymes processing vasoactive precursors in vitro. Arzneimittel-Forschung;, 60, 182–185.
18. Luhtala S, Vaajanen A, Oksala O, Valjakka J and Vapaatalo H, 2009. Activities of angiotensin-converting enzymes ACE1 and ACE2 and inhibition by bioactive peptides in porcine ocular tissues. Journal of Ocular Pharmacology and Therapeutics, 25, 23–28.
19. Mizuno S, Matsuura K, Gotou T, Nishimura S, Kajimoto O, Yabune M, Kajimoto Y and Yamamoto N, 2005. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. British Journal of Nutrition, 94, 84–91.
20. Mizushima S, Ohshige K, Watanabe J, Kimura M, Kadowaki T, Nakamura Y, Tochikubo O and Ueshima H, 2004. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. American Journal of Hypertension, 17, 701–706.
21. Nakamura Y, Yamamoto N, Sakai K and Takano T, 1995. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. Journal of Dairy Science, 78, 1253–1257.
22. Nakamura Y, Kajimoto O, Kaneko K, Aihara K, Mizutani J, Ikeda N and Kajimoto Y, 2004. Effects of the liquid yogurts containing “lactotripeptide (VPP, IPP)” on high-normal blood pressure. Journal of Nutritional Food, 7, 123–137.
23. Sano J, Ohki K, Higuchi T, Aihara K, Mizuno S, Kajimoto O, Nakagawa S, Kajimoto Y and Nakamura Y, 2005. Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. Journal of Medicinal Food, 8, 423–430.
24. Seppo L, Kerojoki O, Suomalainen T and Korpela R, 2002. The effect of a Lactobacillus helveticus LBK-16 H fermented milk on hypertension- a pilot study on humans. Milchwissenschaft, 57, 124–127.
25. Seppo L, Jauhiainen T, Poussa T and Korpela R, 2003. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. American Journal of Clinical Nutrition, 77, 326–330.
26. Sipola M, Finckenberg P, Santisteban J, Korpela R, Vapaatalo H and Nurminen ML, 2001. Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. Journal of Physiology and Pharmacology, 52, 745–754.
27. Sipola M, Finckenberg P, Korpela R, Vapaatalo H and Nurminen ML, 2002. Effect of long-term intake of milk products on blood pressure in hypertensive rats. Journal of Dairy Research, 69, 103–111.
28. Tuomilehto J, Lindstrom J, Hyyrynen J, Korpela R, Karhunen ML, Mikkola L, Jauhiainen T, Seppo L and Nissinen A, 2004. Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension. Journal of Human Hypertension, 18, 795–802.
29. Turpeinen AM, Järvenpää S, Kautiainen H, Vapaatalo H and Korpela R, 2007, unpublished. Meta-analysis of clinical studies on the effects of IPP and VPP on blood pressire in hypertensive subjects.
30. Turpeinen AM, Kumpu M, Rönnback M, Seppo L, Kautiainen H, Jauhiainen T, Vapaatalo H and Korpela R, 2009. Antihypertensive and cholesterol-lowering effects of a spread containing bioactive peptides IPP and VPP and plant sterols. Journal of Functional Foods, 1, 260–265.
31. Turpeinen AM, Ikonen M, Kautiainen H, Vapaatalo H and Korpela R, unpublished. Effects of a spread containing bioactive milk peptides and plant sterol esters on blood pressure in hypertensive subjects.
32. Van der Zander K, Jakel M, Bianco V and Koning MM, 2008a. Fermented lactotripeptides-containing milk lowers daytime blood pressure in high normal-to-mild hypertensive subjects. Journal of Human Hypertension, 22, 804–806.
33. Van der Zander K, Bots ML, Bak AA, Koning MM and De Leeuw PW, 2008b. Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects. American Journal of Clinical Nutrition, 88, 1697–1702.
34. Van Mierlo LA, Koning MM, Van der Zander K and Draijer R, 2009. Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies. American Journal of Clinical Nutrition, 89, 617–623.
35. Wuerzner G, Peyrard S, Blanchard A, Lalanne F and Azizi M, 2009. The lactotripeptides isoleucine-proline-proline and valine-proline-proline do not inhibit the N-terminal or C-terminal angiotensin converting enzyme active sites in humans. Journal of Hypertension, 27, 1404–1409.
36. Xu JY, Qin LQ, Wang PY, Li W and Chang C, 2008. Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition, 24, 933–940.